Pediatric Oncology Treatment Market: Introduction
- Childhood cancer is a term used to describe cancer that occurs between birth and 15 years of age. Pediatric cancer is quite rare and could differ from adult cancers in the way they grow. Several cancer treatments are currently available. The type of cancer and stage determine the treatment. The primary cause of childhood cancer is not known; however, researchers assume that 5% of all cancers in children is caused by an inherited mutation. The Children’s Oncology Group (COG) is the world’s largest organization that conducts clinical research to improve the care and treatment of children with cancer.
Key Drivers, Restrains, and Opportunities of Global Pediatric Oncology Treatment Market
- Rise in prevalence of cancer, favorable reimbursement scenario, and health care reforms are the major factors boosting the growth of the global pediatric oncology treatment market. According to WHO data (2018), cancer is a leading cause of death among children and adolescents across the world; nearly 300,000 children aged between 0 and 19 are diagnosed with cancer each year. Moreover, in 2018, the WHO launched the Global Initiative for Childhood Cancers with various partners to provide proper childhood cancer programs across the world.
Global Pediatric Oncology Treatment Market: Segmentation
- The global pediatric oncology treatment market can be segmented based on indication, treatment, end-user, and region. In terms of indication, the global market can be classified into leukemia, bone tumors, brain cancers, retinoblastoma, lymphoma, and others. Leukemia accounts for majority of all pediatric cancers. The segment is projected to dominate the market during the forecast period, as it is the most common childhood cancer. Based on treatment, the global pediatric oncology treatment market can be categorized into chemotherapy, radiotherapy, tumor surgery, and blood & marrow transplantation. The chemotherapy segment is anticipated to account for significant share of the market during the forecast period. Drugs used in chemotherapy can effectively destroy cancer cells. This factor drives the segment. In terms of end-user, the global market can be divided into hospitals, specialty clinics, and cancer & radiation therapy centers. The hospitals segment is expected to expand at a high CAGR during the forecast period owing to high patient preference for these settings for cancer treatment.
North America to Capture Major Share of Global Pediatric Oncology Treatment Market
- In terms of region, the global pediatric oncology treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2018. The region is projected to account for significant share of the global market due to well-defined reimbursement policies from public and private health insurance firms, which helps patients to avail surgery and other treatment options. According to the National Cancer Institute, in early 2019, around 11,000 new cases of childhood cancer were diagnosed in the U.S. An estimated 6,000 childhood cancer patients succumb to the disease in Europe each year. Asia Pacific is expected to account for significant share of the market in terms of revenue during the forecast period due to rise in awareness about the different treatment options for pediatric.
Key Players Operating in Global Pediatric Oncology Treatment Market
The global pediatric oncology treatment market is highly fragmented due to the presence of large number of key players. Growth strategies adopted by leading players are likely to drive the global pediatric oncology treatment market.
Major players operating in the global pediatric oncology treatment market are:
- Royal Children’s Hospital
- St. Jude Children’s Research Hospitals
- Birmingham Women’s and Children’s
- The National Center for Child Health and Development
- The Vanderbilt University Medical Center
- St. Louis Children’s Hospitals
- SSM Health
- Other prominent players
Global Pediatric Oncology Treatment Market: Research Scope
Global Pediatric Oncology Treatment Market, by Indication
- Leukemia
- Bone Tumors
- Brain Cancers
- Retinoblastoma
- Lymphoma
- Others
Global Pediatric Oncology Treatment Market, by Treatment
- Chemotherapy
- Radiotherapy
- Tumor Surgery
- Blood & Marrow Transplantation
Global Pediatric Oncology Treatment Market, by End-user
- Hospitals
- Specialty Clinics
- Cancer & Radiation Therapy Centers
Global Pediatric Oncology Treatment Market, by Region
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
